NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$6,082
-9.1%
2340.0%0.00%
Q1 2024$6,692
-6.5%
2340.0%0.00%
Q4 2023$7,160
-49.1%
234
-55.3%
0.00%
Q3 2023$14,080
+34.3%
524
+78.2%
0.00%
Q2 2023$10,484
+40.4%
2940.0%0.00%
Q1 2023$7,468
-37.4%
2940.0%0.00%
Q4 2022$11,925
+19.2%
2940.0%0.00%
Q3 2022$10,0000.0%2940.0%0.00%
Q2 2022$10,000
-9.1%
294
+25.6%
0.00%
Q1 2022$11,000
-47.6%
234
-27.6%
0.00%
Q4 2021$21,000
+40.0%
323
+38.0%
0.00%
Q3 2021$15,000
-21.1%
2340.0%0.00%
Q2 2021$19,000
+18.8%
2340.0%0.00%
Q1 2021$16,000
-11.1%
2340.0%0.00%
Q4 2020$18,000
+80.0%
2340.0%0.00%
Q3 2020$10,0000.0%2340.0%0.00%
Q2 2020$10,000
+11.1%
234
-22.5%
0.00%
Q1 2020$9,000
-40.0%
302
+29.1%
0.00%
Q4 2019$15,000
+114.3%
2340.0%0.00%
Q3 2019$7,000
+250.0%
234
+185.4%
0.00%
Q1 2019$2,000820.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders